Giulia Odorici

843 total citations
44 papers, 367 citations indexed

About

Giulia Odorici is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Giulia Odorici has authored 44 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 22 papers in Dermatology and 10 papers in Rheumatology. Recurrent topics in Giulia Odorici's work include Psoriasis: Treatment and Pathogenesis (25 papers), Dermatology and Skin Diseases (13 papers) and Autoimmune Bullous Skin Diseases (6 papers). Giulia Odorici is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (25 papers), Dermatology and Skin Diseases (13 papers) and Autoimmune Bullous Skin Diseases (6 papers). Giulia Odorici collaborates with scholars based in Italy, United States and United Kingdom. Giulia Odorici's co-authors include Andrea Conti, Federico Bardazzi, Giovanni Pellacani, Annalisa Patrizi, Riccardo Balestri, Vincenzo Bettoli, Claudia Lasagni, Michela Magnano, Victor Desmond Mandel and Giuseppe Monfrecola and has published in prestigious journals such as Scientific Reports, British Journal of Dermatology and Lara D. Veeken.

In The Last Decade

Giulia Odorici

42 papers receiving 362 citations

Peers

Giulia Odorici
Lieke J. van Vugt Netherlands
Giulia Odorici
Citations per year, relative to Giulia Odorici Giulia Odorici (= 1×) peers Lieke J. van Vugt

Countries citing papers authored by Giulia Odorici

Since Specialization
Citations

This map shows the geographic impact of Giulia Odorici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Odorici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Odorici more than expected).

Fields of papers citing papers by Giulia Odorici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Odorici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Odorici. The network helps show where Giulia Odorici may publish in the future.

Co-authorship network of co-authors of Giulia Odorici

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Odorici. A scholar is included among the top collaborators of Giulia Odorici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Odorici. Giulia Odorici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piaserico, Stefano, Matteo Megna, Federico Bardazzi, et al.. (2025). TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study. Lara D. Veeken. 64(11). 5803–5810.
2.
3.
Bardazzi, Federico, Claudia Lasagni, Laura Bigi, et al.. (2024). Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. Dermatology Practical & Conceptual. 14(3). e2024171–e2024171. 1 indexed citations
4.
Micali, Giuseppe, Vincenzo Bettoli, Giulia Odorici, et al.. (2023). The Impact of COVID-19 Pandemic on Acne Patients and Their Management: An Observational Multicenter Study from Italy. Cosmetics. 10(6). 146–146. 1 indexed citations
5.
Borghi, Alessandro, Giulia Odorici, Federico Bardazzi, et al.. (2023). Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study. Italian Journal of Dermatology and Venereology. 158(1). 26–31. 1 indexed citations
6.
Bardazzi, Federico, Vito Di Lernia, Alberico Motolese, et al.. (2023). Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study. Acta Dermato Venereologica. 103. adv4526–adv4526. 2 indexed citations
7.
Ribero, Simone, Gabriella Fabbrocini, Vincenzo Bettoli, et al.. (2021). Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting. Journal of the European Academy of Dermatology and Venereology. 35(7). e441–e442. 39 indexed citations
8.
Lai, Michela, Riccardo Pampena, Giulia Odorici, et al.. (2021). Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature. International Journal of Dermatology. 61(5). 548–557. 15 indexed citations
9.
Piaserico, Stefano, Andrea Conti, Francesco Messina, et al.. (2021). Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis. BioDrugs. 35(4). 469–471. 7 indexed citations
10.
Patrizi, Annalisa, Andrea Conti, Claudia Lasagni, et al.. (2021). Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experience. Italian Journal of Dermatology and Venereology. 157(4). 313–317. 6 indexed citations
11.
Odorici, Giulia, Valeria Righi, Alessia Paganelli, et al.. (2021). Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis. Scientific Reports. 11(1). 10472–10472. 18 indexed citations
12.
Odorici, Giulia, Alessia Paganelli, Johanna Chester, et al.. (2021). Moderate to severe psoriasis: a single-center analysis of gender prevalence. Italian Journal of Dermatology and Venereology. 156(2). 226–230. 5 indexed citations
13.
Odorici, Giulia, Giovanni Pellacani, & Andrea Conti. (2021). Ixekizumab in hidradenitis suppurativa in a psoriatic patient. Giornale Italiano di Dermatologia e Venereologia. 155(6). 788–789. 16 indexed citations
14.
Bardazzi, Federico, Michela Magnano, Giulia Fiorini, et al.. (2021). Helicobacter pylori infection in psoriatic patients during biological therapy. Italian Journal of Dermatology and Venereology. 156(5). 570–574. 5 indexed citations
15.
Bardazzi, Federico, et al.. (2020). Cyclosporine in clinical practice: a retrospective study comparing fixed dose and body weight-based dose regimens in psoriatic patients. Giornale Italiano di Dermatologia e Venereologia. 155(2). 146–149. 2 indexed citations
16.
Chiricozzi, Andrea, Andrea Conti, Martina Burlando, et al.. (2019). Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience. Dermatology. 235(3). 213–218. 9 indexed citations
17.
Balestri, Riccardo, et al.. (2018). Survey of bullous pemphigoid in an Italian university hospital: clinical-epidemiological characteristics and follow-up. Giornale Italiano di Dermatologia e Venereologia. 153(5). 613–618. 2 indexed citations
18.
Conti, Andrea, Stefano Piaserico, Paolo Gisondi, et al.. (2017). Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting. Dermatologic Therapy. 30(5). e12503–e12503. 11 indexed citations
19.
Bardazzi, Federico, et al.. (2013). Interdigital Psoriasis of the Feet (Psoriasis Alba): Not a Distinct Form of Psoriasis. Dermatology. 227(2). 130–133. 3 indexed citations
20.
Bardazzi, Federico, et al.. (2013). 36‐wöchige retrospektive offene Studie zum Vergleich der Wirksamkeit von Biologika bei Nagelpsoriasis. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 11(11). 1065–1072. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026